Suzhou Industrial Park, China

Shu Yu

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Neurogastrx, Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shu Yu. Retrieved from https://idiyas.com/inventor/shu-yu-cydw8azu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Shu Yu in the Field of Medicine

Introduction

Shu Yu is a prominent inventor based in Suzhou Industrial Park, China. She has made significant contributions to the field of medicine, particularly in the development of novel pharmaceutical compounds. With a total of three patents to her name, her work focuses on improving treatment methods for various medical conditions.

Latest Patents

One of her latest patents includes the development of polymorphic forms of metopimazine. These novel polymorphic forms of metopimazine mesylate are particularly useful in methods, compositions, and kits for the treatment of enteric nervous system disorders. This innovation highlights her commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Shu Yu currently works at Neurogastrx, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise in polymorphic forms has positioned her as a key player in the development of new therapeutic options. Her dedication to her work is evident in the quality and impact of her inventions.

Conclusion

Shu Yu's contributions to the field of medicine through her innovative patents demonstrate her significant role as an inventor. Her work not only advances scientific knowledge but also has the potential to improve the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…